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Abstract: Down syndrome (DS) is related to diseases like congenital heart disease, obstructive sleep 
apnea, obesity and overweight. Studies focused on DS associated with obesity and overweight are 
still scarce. The main objective of this work was to analyze the relationship between dietary inter-
vention, physical exercise and body composition, in DS with overweight and obesity. This review 
is based on the PRISMA guidelines (Preferred Reporting Items for Systematic reviews and Meta-
Analyses). Selection criteria for this analysis were: publications between January 1997 and Decem-
ber 2019; DS individuals with overweight and obesity; clinical trials using dietary intervention and 
physical exercise paying attention to changes in body composition. Selected clinical trials were fo-
cused on an exclusive intervention based on physical exercise. The anthropometric measures ana-
lyzed were body fat, BMI, waist circumference, body weight and fat free mass. The main conclusion 
is that prescribing structured physical exercise intervention may be related to a greater variation in 
body composition. Despite limited number of clinical trials analyzed, it can be assumed that the 
reported studies have not achieved optimal results and that the design of future clinical trials should 
be improved. Some guidelines are proposed to contribute to the improvement of knowledge in this 
field. 
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1. Introduction 
Down Syndrome (DS) (OMIM#190685, Online Mendelian Inheritance in Man®, An Online Cata-
log of Human Genes and Genetic Disorders) is a genetic disorder caused by a trisomy of chromosome 
21 and is the most common genetic cause of intellectual disability (ID) [1]. DS is associated with sig-
nificant health problems as diseases such as congenital heart disease, obstructive sleep apnea, celiac 
disease and endocrinopathologies. Endocrine disorders are usually characterized by thyroid disor-
ders, low bone mass, diabetes, short stature and propensity to be overweight/obese [1,2]. 
Life expectancy of people with DS has increased significantly from 12 years in 1949, to 60 years 
in 2004, and it is expected to increase in the near future [1,2]. Unfortunately, the increase in life ex-
pectancy is not parallel to the increase in the period of life with optimal health. Accelerated aging is 
identified in the case of DS based on two aspects: a. Clinical-pathological characteristics of the subject; 
b. Monitoring of molecular markers related to biological age and the aging process, highlighting the 
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shortening of the telomeres [1]. Thus, several studies have connected the shortening of the telomeres 
with obesity, and particularly with the increase of BMI and adiposity causing accelerated aging [3,4]. 
Currently, there is a higher prevalence of overweight in ID patients (≥18 years) compared to 
those not affected by IDs, both in obesity (38.3% vs. 28%) and in morbid obesity (7.4% vs. 4.2%) [5]. 
Prevalence in overweight and obesity varied between 23–70% in DS patients (13.3–52.9 and 0–62.5%). 
Thus, young people with DS have higher rates of overweight and obesity than young people without 
DS [6].  
The causes of the development of overweight and obesity in DS are: hypotonia (decreased mus-
cle tone), susceptibility to systemic inflammation, metabolic diseases and/or slow metabolism [7]. 
Usually, people affected by DS consume less healthy food, and show physical limitations, depression, 
and lack of social and financial support. Besides, medications contribute to weight gain [8]. The key 
challenge for this field of knowledge in incoming years will be to identify therapeutic intervention 
strategies for weight loss that reduce body fat and systemic inflammation [6,9]. Therefore, there is a 
need to increase evidence-based clinical knowledge, with the aim of improving existing care pro-
grams [2,10,11].  
Among the approaches used to monitor obesity and overweight, anthropometry reveals as one 
of the most efficient, cheaper and less time consuming. Anthropometry is considered a branch of 
biological anthropology; it is responsible for studying any physiological, psychological or anatomical 
trait. It is a powerful tool for the evaluation of nutritional status in the clinical environment and is 
used for general nutritional monitoring. Between the parameters measured, height and weight meas-
urements are simple and quick. Other more complex measures include skin folds and circumferences, 
which require more professional training and involve different degrees of error [12]. To avoid errors 
or biases of these measurements, it is advisable to follow a protocol to measure these anthropometric 
variables, for example: the methodology ISAK (International Society for the Advancement of Cine-
anthropometry) [13–15].  
In carrying out studies of an anthropometric nature, different methodologies have been devel-
oped during the last decades that have given rise to the following three groups: (i) Direct (dissection 
of corpses and neutron activation analysis); (ii) Indirect (hydrostatic densitometry; isotopic solution; 
total body potassium; DXA, dual X-ray absorptiometry; CT, computed tomography; QMR, quantita-
tive magnetic resonance; ADP, air displacement plethysmography); (iii) Mixed or doubly indirect 
(Skin folds; BIA, bioelectrical impedance analysis and ultrasound) [16]. The measurement methods 
in the “Gold Standard” body composition to provide more information and to have greater accuracy 
are: full-body computerized tomography, four-compartment models (fat mass, muscle mass, other 
tissues and bone mass) and dual absorptiometry of X-rays. Here, accuracy is defined as the variation 
of body composition between different measurements in the same subject [17]. However, the most 
used methods in the clinical daily routine are: Skin folds; BIA and ultrasound [16,17]. 
Considering all the previous mentioned issues as well as the advantages of using anthropomet-
ric parameters to monitor nutritional status and obesity, the low number of studies about obesity and 
overweight in people with DS is striking. Consequently, this research is justified by the following 
facts:  
1. DS individuals are characterized by high rates of overweight and obesity and low-quality life 
[1,6]. 
2. Obesity has negative health effects and lowers life expectancy [3,4]. 
3. Consumption of less healthy foods, lower levels of physical activity and medication are factors 
that enhance weight gain in DS [8].  
4. There is a need to increase evidence-based clinical knowledge [2,10,11]. 
Thus, the main objective of this systematic review was to analyze the effectiveness of described 
interventions (based on dietary intervention and/or physical exercise) on the improvement of body 
composition and anthropometric parameters in people suffering from DS with overweight and obe-
sity. As secondary objectives, the following have been identified: (i) To evaluate the methodological 
design quality of the CONSORT 2010 guidelines; (ii) To indicate the anthropometric parameters and 
units of measurement that record changes in body composition, in subjects with DS, overweight and 
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obesity; (iii) Evaluation of body composition measuring instruments; (iv) To highlight dietary pat-
terns and physical exercises that cause significant changes in the clinical trials analyzed. At the time 
of writing this work, the number of clinical studies performed involving the use of anthropometry to 
study DS individuals is low and criteria used are disparate. It is therefore necessary to carry out a 
detailed review of the methodology used, and the results achieved with a view to improving future 
interventions. From the results obtained in this analysis some guidelines are proposed to contribute 
to the improvement of knowledge in this field. 
2. Methods 
2.1. Search Strategy and Information Processing 
This systematic review was conducted following the guidelines recommended by PRISMA (Pre-
ferred Reporting Items for Systematic reviews and Meta-Analyses) as well as the recommendations 
of the International Committee of Biomedical Journal Editors [18,19]. The information retrieval sys-
tem “the Boolean model” was used [20].  
The databases used were: PubMed (search engine for free access to the MEDLINE database of 
citations and abstracts of biomedical research articles); Scopus (bibliographic database containing ab-
stracts and citations for academic journal articles); Web of Science (online scientific information ser-
vice, provided by Thomson Reuters, integrated in ISI Web of Knowledge, WOK) (original articles 
based on clinical trials). The keywords were: intellectual disability, Down syndrome, overweight, 
obesity, diet and exercise. These keywords were obtained from the “MeSH database” (Medical Sub-
ject Heading) and NLM (The National Library of Medicine). Controlled vocabulary thesaurus was 
used for indexing articles for PubMed. The search strategies used are displayed in Table 1 and Figure 
1. 
In the “PubMed” database, the advanced form of search was used and the following options 
were selected “title/abstract”, specific date and languages; in “Scopus” the option of “document 
search”, “article title, abstract, keywords” and specific date; in “Web of Science”, the basic search was 
conducted and the following options were selected: theme, specific date and “article”. 
Other details like date or language of the publications were not specified, and the search was 
conducted from January 1997 until December 2019. The open research questions at the beginning of 
this research were: What were the results obtained in the included clinical trials on the base of their 
design?; What are the anthropometric parameters and units of measurement registering changes in 
body composition, in subjects with DS, overweight and obesity?; What are the dietary and physical 
exercise patterns showing changes in body composition in the clinical trials analyzed? 
2.2. Selection of the Articles Previously Identify 
Each of the identified articles were independently analyzed by two researchers. PICOS strategy 
was used to define the eligibility criteria for this revision (population, intervention, comparisons, 
results and characteristics of clinical trials). Criteria included in the search strategy were: patients 
with DS or Trisomy 21 [21], who had been diagnosed in overweight or obese clinical trials; in the 
groups of children and adolescents, age will be less than or equal to 19 years [22], adults will be older 
than 19 years; clinical trial published between 1997 and 2019 in scientific journals in Spanish and 
English. These two languages were selected because they are two of three most spoken languages 
worldwide [23,24]. Besides, those patients involved in the selected studies had undergone an ID 
and/or physical exercise. Only the studies highlighting interest in the changes in body composition, 
through the anthropometric parameters and units of measurement have been included (Tables 2 and 
3) [25–30]. 
The exclusion criteria were patients showing other pathologies (diabetes mellitus, polycystic 
ovaries, etc.); clinical trials using pharmacology, gastric balloon and bariatric surgery; review articles 
and meta-analysis. In the selection of included clinical trials, those studies involving sample groups 
of all ages have been accepted to have a much broader view of the analysis. This has been a standard 
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practice in previous reviews [31,32]. Data were extracted from the following 5 domains [33] (Tables 
2 and 3): 
1. Population: characteristics of the population studied (country of origin, type of diagnostic criteria, 
number, age and gender), inclusion and exclusion criteria. 
2. Interventions: exclusive and multidisciplinary as therapeutic treatments.  
3. Comparators: inclusion of clinical trials, control and intervention groups are identified. In princi-
ple, only the intervention groups receive the therapeutic treatment that should cause changes in 
body composition.  
4. Results: they are identified as variation in body composition, presenting significant and not signif-
icant variations. 
5. Characteristics of clinical trials: authors, year of publication, type of clinical trial, duration of inter-
vention, instrument of analysis of body composition, type of intervention used (exclusive or mul-
tidisciplinary) and body composition variation (measured with different anthropometric parame-
ters and units of measurement).  
2.3. Extraction of Data, Synthesis of Results and Risk of Loss of Information 
Three tables and two figures were designed to perform this review. As first step, all the identified 
articles were listed including details about search engine and search strategy used. From these results, 
the included clinical trials in this work were selected (Figure 1 and Table 1). Clinical trials were 
grouped into several groups (Tables 2 and 3), based on age and type of intervention. Three versions 
of each table were made. To minimize the risk of loss of information in the search of clinical trials, the 
term ID was added (Table 1).  
Tables 2 and 3 were designed to record the characteristics of interest of the included clinical 
trials. The information collected was: author/s; study sample; duration of intervention; interven-
tion/method; the variation of the body composition (body mass index, BMI; body fat, BF; fat-free 
mass, FFM; lean mass, LM; body weight, BW; waist circumference, WC) and the major changes in 
body composition. To identify the variation of these parameters and units, a Yes/No code has been 
used: YES, means that the article includes the analysis of the parameter expressed in its correspondent 
units and NO means that the article does not include the analysis of the parameter. Thus, the most 
significant changes body composition from each clinical trial was registered based on each parameter 
and unit (Tables 2 and 3). 
2.4. Use of the CONSORT 2010 Methodology 
In order to analyze the quality in the design of clinical trials included in this work involving the 
highest variations in body composition, the CONSORT 2010 method has been used (assessment and 
implementation guide on the most appropriate guidelines for the design of randomized trials) [34].  
2.5. Evaluation of Body Composition Measuring Instruments 
To evaluate how body composition has been measured, two groups have been established based 
on the degree of information about the instrument or their accuracy: (i) The level of information pre-
sented on the instruments used (model and its technical characteristics), as well as the monitoring of 
a protocol for the measurement of body composition (Table 4) (ii) The accuracy of the instruments 
has been assessed according to the scale of valuation indicated by Müller MJ and his colleagues [17] 
(p. 183). 
For the first case, the following valuation scale is used (Table 4): (i) High (equivalent to three 
points, and reporting the type of instrument used and the measurement protocol followed); (ii) Mod-
erate (equivalent to two points, and reporting the type of instrument used, but not the follow-up of 
any protocol); iii) Low (equivalent to a point, in this case neither the instrument nor the protocol used 
is indicated); (iv) Anthropometric parameter not measured (equivalent to zero points). The protocols 
used had to show some similarity with those presented in the aforementioned revisions [13,14,35,36]. 
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“Down’s syndrome” OR “Down syndrome” OR “cognitive 
disability” AND overweight OR obesity AND weight OR fat  
AND “physical activity” OR exercise OR weightlifting 
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disability” AND overweight OR obesity AND weight OR fat AND 
feeding OR nutrition OR “nutritional counselling” or diet OR 
“dietary treatment” 
25/2 64/4 44/3 133/9 
“intellectual disability” or “Trisomy 21” AND overweight OR 
obesity AND weight OR fat AND “physical activity” OR exercise 
OR weightlifting 
45/4 94/8 72/7 211/19 
“intellectual disability” or “Trisomy 21” AND overweight OR 
obesity AND weight OR fat AND feeding OR nutrition OR 
“nutritional counselling” or diet OR “dietary treatment” 
33/2 86/4 56/6 175/12 
Summation 
Identified/Included 
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Articles or clinical trials identified: complete list of articles retrieved from various databases (PubMed, Scopus and Web of Science), without having made the 
selection of the clinical trials of interest. Articles or clinical trials included: articles that meet the selection criteria.








































Figure 1. Flow chart in the screening process for the selection of included clinical trials [18]. Legend 
exclusion criteria: 1. Subjects not related to the variation of body composition in patients with excess 
weight; 2. Other intellectual or developmental disabilities that do not include Down syndrome; 3. 
Reviews and/or meta-analysis; 4. Interest in other pathologies (diabetes, hypertension, arthritis, heart 
failure, etc.); 5. Repeated articles; 6. Do not use dietary intervention or physical exercise as main treat-
ments or use the help of pharmacological treatment, surgery or similar; 7. Animal intervention; 8. 
Languages other than English and Spanish; 9. Clinical trials involving children, adolescents and 
adults in the defined intervention groups.
Records identified through 
database searching 
(n = 672)  
Additional records identified 
through other sources 
(n = 0) 
Article deleted (n = 615)  
 
Full-text articles assessed for 
eligibility: (n = 57) 
 
Full-text articles 











Studies included in 
qualitative synthesis 
(n = 6) 
Items deleted by being 
repeated (n = 43) 
Elements eliminated due to not 
having 100% of subjects with 
Down syndrome in any of 
their intervention groups  
(n = 8) 
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IG1, n = 16 
IG2, n = 15 
CG, n = 10 
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IG1: 15.7 ± 2.7 years  
IG2: 16 ± 2.8 years 
CG: 14.4 ± 2.5 years 
 







Comparative analysis:  
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IG1 (group aerobic training) 
IG2 (training group resistance) 
CG (control group) 
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IG1 vs. CG 
IG2 vs. CG 























p < 0.05 
 
 
p < 0.05 
















p < 0.05 
















IG1: −0.7 kg  
IG2: −0.1 kg 





CG: 2.7%  
 
BMI:  
IG1: −0.5 kg/m2  
IG2: −0.2 kg/m2 
CG: 0 kg/m2 
 
WC:  
IG1: −1.1 cm 
IG2: −0.1 cm 






n = 18 (55.5% male) 
 
Age: 5–9 years 
 



















p < 0.01  
BF: +0.18% 
 
BMI: −0.16 kg/m2 
 







n = 22 (100% male) 
 
Age: 16.2 ± 1.0 years 
 






p < 0.05 
YES (kg/%) 
 






NO BW: −3.6 kg 
 
BF: −5.5 kg/−5.8% 
 
FFM: +1.8 kg/+5.8% 
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Body composition (BC); Down syndrome (DS); intervention group (IG); intellectual disability (ID); percentage (%); body mass index (BMI); body fat (BF); body weight (BW); fat-free mass (FFM); lean 
mass (LM); randomized clinical trial (RCT); waist circumference (WC); not significant (NS); the article includes the analysis of the parameter expressed in its correspondent units (YES); the article does 
not include the analysis of the parameter (NO); not specified (NE); minutes (min); week (wk); day (d); kilocalorie (Kcal). 
Table 3. Clinical trials including adults suffering DS in which the variation of body composition was analyzed (intervention in physical exercise). 
Reference 
[28–30] 
Location Study Design 
Sample/Groups/Charact
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Anthropometric Parameters (Statistical Results) 
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CG: +0.1 kg 
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IG1: −1.4 kg/−1.3% 
IG2: −1.2 kg /−0.8% 
CG: +2.3 kg /−0.7% 
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IG1: −0.8 kg/m2 
IG2: −0.4 kg/m2 
CG: −0.3 kg/m2 
 
WC:  
IG1: −0.4 cm 
IG2: −1.3 cm 











Age: 18–30 years 




Comparative statistical:  
 












p < 0.05 
NS 








p < 0.05 
NS 






p < 0.05 
NS 
p < 0.05 
BF: −3.9% 
 
BMI: −3.4 kg/m2 
 
WC: −3.2 cm 
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Age: 18–30 years 
BMI: >30 kg/m2 
 
Duration: 2.5 months 
 
 
Comparative analysis:  
 
Within groups:  
IG  
CG 









p < 0.05 
NS 
p < 0.05 
NO 
 





p < 0.05 
NS 
p < 0.05 
BF:  





IG: −3.2 cm  
CG: NE 
Down’s syndrome (DS); intervention group (IG); intellectual disability (ID); percentage (%); body mass index (BMI); body fat (BF); continuous aerobic training (CAT); fat-free mass (FFM); lean mass 
(LM); body weight (BW); randomized clinical trial (RCT); waist circumference (WC); not significant (NS); the article includes the analysis of the parameter expressed in its correspondent units (YES); the 
article does not include the analysis of the parameter (NO); not specified (NE); minutes (min); week (wk); day (d); kilocalorie (Kcal).
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3. Results  
3.1. Search Features and Types of Interventions Identified 
Only 1% of the identified clinical trials have been included in this work to do the complete anal-
ysis. The Scopus database and the third search strategy provided most of the included trials (Figure 
1 and Table 1). 
Five clinical trials have been included in the study (6 papers, because Ordoñez and coworkers 
[a] and Ordoñez and coworkers [b] referred to the same study, but both have been included because 
they report some different parameters) (Tables 2 and 3) [29,30]. Three of the studies involve children 
and adolescent populations (Table 2) and two of them work with adult patients (Table 3). 
As a response to the second secondary objective, all of them were focused on an exclusive inter-
vention based on physical exercise and the anthropometric measures analyzed were BF (in kg or %, 
100%), BMI (in kg/m2, 80%), WC (in cm, 80%), BW (in kg, 60%) and FFM (in kg or %, 20%). A period 
of intervention between ten and twelve weeks was defined in all cases.  
3.2. Instruments for Measuring Body Composition 
As it is displayed in Table 4, there are no significant differences in the level of information about 
the instruments used when evaluating children, adolescents and adults. Clinical trials that present 
more complete information and with less error/measurement bias (because they have followed a spe-
cific protocol) are those developed by Ordoñez and co-workers and Boer and co-workers [27,28].  
For the evaluation of the instruments that measured fat mass, and in some cases fat-free mass, 
the precision scale indicated by Müller and colleagues was used, where the greatest precision was 
related to the smallest variation between the results when the measurement of body composition in 
a subject is repeated, and the lowest accuracy in the opposite case [17] (p. 183). Thus, the following 
groups were obtained: (i) The clinical trials of Seron, Boer and two of Ordoñez were the most accurate 
[25,28–30]; (ii) The other clinical trials used instruments of less precision [26,27]. The instruments used 
for measuring body fat were: (i) Bod Pod® plethysmography equipment, body composition was cal-
culated based on the equation of Siri (Life Measurement Inc., Concord, CA, USA) [25]; (ii) The per-
centage of fat mass was estimated through the summation of the four folds (triceps, biceps, subscap-
ular and suprailiac regions) on the right side using the caliper de Lange and as the standard of refer-
ence to West’s rate and Deurenberg [26]; (iii) Percentage of fat mass was calculated from measure-
ments according to the equation Durnin-Womersley using a Holtain lipometer (Holtain Ltd., 
Crymych, Dyfed, Wales, UK). [27]; (iv) Body composition was assessed by bioelectrical impedance 
analysis (Bodystat 1500 MDD, Douglas, Isle of Man, UK) [28]; (v) The percentage of fat mass was 
measured by bioelectrical impedance analysis (Tanita TBF521 bioelectrical) [29]; (vi) Fat-mass per-
centage was assessed by bioelectrical impedance analysis (Tanita TBF521) [30]. 
Considering the evaluations carried out, the third secondary objective is answered: most clinical 
trials about DS show a moderate level of information (it is not indicated whether or not a protocol 
has been followed in making measurements) and most instruments used to measure body fat and 
fat-free mass show a high level of accuracy. 
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Children and adolescents     
[25] Moderate Moderate High   Moderate Moderate (2.3)  
[26] Moderate Moderate Moderate High   Moderate (2.3) Moderate (2.4) 
[27] Moderate High   High   APNM Moderate–High (2.7)  
Adults      
[28] High Moderate High   High   Moderate–High (2.8)  
[29] Moderate Low Moderate Moderate Low–Moderate (1.8) Moderate (2.2) 
[30] APNM  Low Moderate High   Moderate (2)  
APNM: anthropometric parameter not measured; fat-free mass (FFM); body fat (BF); body weight 
(BW); randomized clinical trial (RCT); waist circumference (WC) 
3.3. Evaluation of the Design of Clinical Trials 
In order to analyze the quality of the design of controlled clinical trials included in this work 
involving the highest variations in body composition (Seron and coworkers, Boer and coworkers and 
Ordoñez and coworkers) [25,28–30]. The CONSORT 2010 method has been used (assessment and 
implementation guide on the most appropriate guidelines for the design of randomized trials) [34]. 
Negative results should be considered for items that have not been performed or have been incom-
pletely performed. Positive results are those in which the items were fulfilled entirely. Items related 
to the randomization process were eliminated for the analysis of the non-randomized trial [25].  
As a response to the first secondary objective, positive results have been reported from half of 
the clinical trial analyzed. However, in no case, the percentage of positive responses was greater than 
65%. 
3.4. Changes in Body Composition in Down Syndrome: Children and Adolescents  
The three trials focused on children and adolescents were reported from Brazil, Chile and Spain, 
respectively [25–27]. Seron and coworkers, presented a quasi-experimental study in which the 41 pa-
tients (15.7 ± 2.7 years old) were assigned to two intervention groups plus a control group (n = 16, n 
= 15 and n = 10, respectively). The patients grouped in the intervention groups underwent two differ-
ent types of training: aerobic (intensity of 50–70% of heart rate reserve 3 times per week) and re-
sistance (12 maximum repetitions 2 times per week). The anthropometric measures analyzed were 
BW, BF, BMI and WC. Regarding to BW and BF, significant differences were not observed within the 
intervention groups nor between them. However, the differences were significant with respect to the 
control group and the two groups in BF but not in BW. The largest changes in BW occurred in the 
first group (0.7 kg), while in BF in the second one (0.5%). In BMI and WC, significant differences were 
observed within the first group (with changes of 0.5 kg/m2 and 1.1 cm, respectively), but not in the 
other one. Regarding BMI, there were significant differences in the second intervention group with 
respect to the other two groups, but these differences were already significant in the baseline values 
(Table 2).  
The other two articles presented interventions related to physical exercise in a single group of 
patients. Mosso and coworkers, reported an intervention in a group of 18 children between 5 and 9 
years old. The intervention consisted in the application of a physical exercise program with different 
aerobic and resistance activities. The anthropometric measurements analyzed were BF, BMI and WC. 
BF increased and only significant differences in WC were obtained, with changes of around 3.07 cm. 
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Ordoñez and coworkers applied a physical exercise intervention on a group of 22 male adolescents 
with a mean age of 16.2 ± 1.0 years. The training included exercises in water and land three times per 
week. The anthropometric measurements analyzed were BF and FFM (in kg and %) and BW. There 
were significant differences in BW and BF (changes of 3.6 kg in BW and 5.5 and 5.8% in BF) [27] (Table 
2). 
Regarding to BW (kg) and BF (kg and %), Ordoñez and coworkers reported the greatest changes 
in three months in a group from baseline, and the greatest variation was 3.6 kg, 5.5 kg and 5.8%, 
respectively [27]. It is important to highlight that the number of studies here included that follow 
inclusion and exclusion criteria was small. Consequently, these comparisons maybe are not signifi-
cant and conclusive enough (Table 2 and Figure 2). 
 
Figure 2. Within-group differences (with 95% confidence interval) in children and adolescents trials. 
Considering the number of clinical trials analyzed, the fourth secondary objective is answered. 
The main finding regarding BMI (kg/m2) is that Seron and co-authors reported the greatest changes 
in three months and the greatest variation was 0.5 kg/m2 [25]; with respect to WC (cm), Mosso and 
coworkers, reported the greatest changes in three months and the greatest variation was 3.07 cm [26] 
(Table 2). 
3.5. Changes in Body Composition in Down Syndrome: Adults  
Regarding to trials focused on adults, Boer and coworkers, described an experimental study lo-
cated in the Republic of South Africa, in which the 42 patients (33.8 ± 8.6 years old, and 71.4% of 
female) were assigned to two interventions and a control group (n = 13, n = 13 and n = 16, respectively). 
The patients in the intervention groups underwent two different types of training: interval training 
(IT) versus continuous aerobic training (CAT). The anthropometric measures analyzed were BW, BF, 
BMI and WC. The significance of the differences within each group was not reported, but the differ-
ences between groups are not significant in BF and WC. On the contrary, in BW there are significant 
differences in the comparisons between the three groups, obtaining the greatest changes in the IT 
group (2.3 kg). In BMI no significant differences were observed between CAT groups and the control 
group, but between IT and the other two groups being the drop in this group of 0.8 kg/m2 (Table 3). 
The other trial was reported by Ordoñez and coworkers, in which 21 females (between 18 and 
30 years old) were randomly assigned to the intervention group (n = 11) participating in an aerobic 
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training of three sessions per week, whilst the other 10 were assigned to a control group. The trial 
was conducted in Spain and the anthropometric measures analyzed were BF, BMI and WC. All 
measures showed significant changes in the intervention group, but the differences between the 
groups were not reported. Changes in the measures in the intervention group were 3.9%, 3.4 kg/m2 
and 3.2 cm, respectively [29,30] (Table 3). 
Considering the number of clinical trials analyzed, the fourth secondary objective is answered: 
regarding to BF (kg), Boer and coworkers, reported the greatest changes in three months and the 
greatest variation was 1.4 kg [28]; with respect to BF (%), BMI (kg/m2) and WC (cm), Ordoñez and 
coworkers, reported the greatest changes in two and a half months and the greatest variations were 
3.9%, 3.4 kg/m2 and 3.2 cm, respectively [29]. Due to the small number of studies analyzed regarding 
this issue (2 works on DS in adults) the conclusions to be obtained may not be accurate and significant 
enough (Table 3).  
4. Discussion 
Down syndrome is the most commonly occurring genetic chromosomal disorder and its esti-
mated incidence is between 1 in 1000 to 1 in 1100 live births worldwide, according to the World 
Health Organization [37]. People suffering from DS are more likely to be overweight or obese than 
the general population [6]. Despite this, the number of studies (even clinical trials) on DS in connec-
tion with overweight or obesity is significantly low compared to other diseases. The lack of 
knowledge on this field justified from the very beginning this systematic review, which has been 
difficult to conduct because of the low number of clinical trials identified on this topic. Consequently, 
it has not been possible to address accurately the main objective. However, in view of the scarcity of 
knowledge in this area, it was decided to carry out this work, not only to identify what has been 
described so far, but also to highlight the need to deepen this field of research, from both levels basic 
and applied. Thus, three main limitations have been identified in this review: (i) Small number of 
studies based on clinical trials; (ii) Absence of clinical trials with dietary intervention; and (iii) Ab-
sence of studies based on multidisciplinary interventions.  
In order to analyze the information described so far on DS and overweight or obesity, the first 
approach was to evaluate the degree of information described in each study on the anthropometric 
measures carried out and the type of instrument used for the measurement. Regarding the level of 
information presented by each clinical trial on the measurements of body composition, it can be seen 
that in most clinical trials they are not following specific, standardized protocols for their measure-
ment (Table 4) [13,14,35,36]. This information is of concern in clinical trials measuring body fat by 
measuring skin folds, because it is a method whose accuracy is lower due to errors resulting from 
measurement without a specific protocol [17] (p. 183). Among the instruments analyzed, the measur-
ing tape and the skin fold register are sensitive measurement methods with variability in accuracy. It 
should therefore be stressed that in the future it is essential to use protocols for the different meas-
urement techniques applied in order to ensure that the measures are reliable and reproducible [14–
16]. In this sense, it is of special importance to identify two aspects: (i) The validity, precision and 
nature of the parameters that are monitored to estimate the body composition (without losing sight 
of both the daily and inter-individual variation); (ii) The variation of results according to the protocols 
of study used and the dynamics of weight changes (before, during and after the intervention) [38]. 
As a reflection, it is advisable to convey that despite the existence of more precise methods, it is pos-
sible to use any of the named methods if a protocol is used to decrease the variation in precision. In 
this way, changes in obesity can be monitored in response to the investment of time and money re-
quired for the monitoring. 
In this review it has been found that the strategies that allowed greater changes in body compo-
sition, in children and adolescents were those base on planned physical exercise, considering the in-
tensity, the duration, the number of repetitions, days per week and with programming by macrocy-
cles, are the techniques that cause the greatest variation in body composition. The gradual increase 
of load in time and intensity is a technique that was also considered in two studies [25,26]. In the case 
of adults, the best results were observed when planned physical exercise was prescribed taking into 
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consideration the intensity, duration, number of repetitions and days per week, including the contin-
uous aerobic exercise [28,29]. In the absence of more evidences, the guidelines for dietary intervention 
and physical exercise in children, adolescents and adults with overweight or obesity without DS re-
main the main references to follow [39–42]. When prescribing physical exercise, it is recommended 
to use guidelines reporting positive results. These guidelines should follow the recommendations 
given in this review and by the American College of Sports Medicine (including degrees of evidence 
and greater accuracy in prescribing physical exercise) [43,44] (pp. 460, 1336). 
In general terms, it can be concluded that there is a shortage of research personnel focused on 
this area of knowledge, as well as deficiencies in the means and infrastructures available for these 
studies. Therefore, research in this field, training of clinical staff in specific aspects of DD, and high-
quality clinical care for subjects with this syndrome should be enhanced [10,45].  
Regarding to the design of clinical assays involving DS individuals, it is worth mentioning that 
guidelines like CONSORT 2010 should be used [34] (p. 31), and studies involving individuals only 
suffering from DS has to be conducted [46] (pp. 137–140), so that dietary and multidisciplinary inter-
vention is used to promote change in body composition. At the time of writing this review, most of 
the studies involved patients showing more diseases apart from DS, which makes difficult to estab-
lish correlations between changes of the measured parameters and exclusively DS. 
As cited in the introduction and in Section 3.2, different type of instruments are used to measure 
key anthropometric parameters. Most instruments used to measure body fat and fat-free mass show 
a high level of accuracy in the analyzed studies, however, no clear protocols used to take the meas-
urements are referred, which is a significant limitation of these reported studies. Apart from these 
instruments, the use of accelerometers as a precision method for evaluating physical activity is also 
suggested [47,48]. 
Among the issues to be considered in the design of further studies involving DS and obesity or 
overweight, the following should be included: cardiorespiratory fitness and analysis at molecular 
level. Cardiorespiratory fitness as a feasible method in subjects with DS without congenital heart 
disease. This approach is also useful to measure the level of physical condition in order to perform a 
safe physical activity [49]. Cardiorespiratory fitness is defined as the ability of the circulatory, respir-
atory and muscular systems to deliver oxygen during sustained physical activity. Records found in 
individuals with intellectual disabilities indicate a low level; levels in children, adolescents and men 
with intellectual disabilities are already low and decrease further with increasing age [50,51]. Regard-
ing to the analysis at molecular level, it is important to mention that not only the shortening of the 
telomeres [1], but also other molecular targets like molecules sustaining systemic inflammation, hor-
mones or peptides like leptin and adiponectin have to be considering to monitor obesity and over-
weight in DS. Recently it has been described that leptin is at higher concentration in young subjects 
with DS and adiponectin is higher in older subjects [52]. So, it is possible to establish correlations 
between leptin and adiponectin over time in DS as a tool to monitor weigh changes in people suffer-
ing from DS. 
If all these objectives could be explored in the short term reaching positive results, it would be 
possible to assume that the monitoring of the variation of body composition through dietary inter-
vention and physical exercise, could be an area of knowledge that contributes to the slowing down 
of aging in subjects with DS [1–4], allowing also the decrease of the high prevalence of overweight 
and obesity [6].  
5. Conclusions 
Down syndrome (DS) with overweight and obesity constitutes a field of knowledge in which 
research should continue with the aim of analyzing relationship between dietary intervention, phys-
ical exercise and body composition variation. From the results of this systematic review, it can be 
concluded that the studies carried out to date have not achieved optimal results and that the design 
of future clinical trials should be improved. Only reinforcing the knowledge related to this topic will 
improve daily clinical practice in sports sciences, nutrition and dietetics as well as in public health 
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will improve. An increase in body composition variation will help to reduce the side effects of over-
weight and obesity, leading to a reduction in healthcare costs.  
Author Contributions: R.M.M.-E.: selection of the information of interest in the tables; information analysis us-
ing the PRISMA methodology; writing, translation and revision of the manuscript. M.D.M.V.: selection of infor-
mation of interest displayed in the tables; information analysis using the PRISMA methodology; analysis of 
clinical trials included by the CONSORT 2010 guide; writing, translation and revision of the manuscript. M.R.G.-
G.: collaborated in the selection of the included clinical trials; elaboration and design of the tables and the flow 
diagram; analysis of clinical trials included by the CONSORT 2010 guide; information analysis using the 
PRISMA methodology; writing of the manuscript draft and revision of the manuscript. All authors have read 
and agreed to the published version of the manuscript. 
Funding: This research has been partially funded by VIGROB-309 (University of Alicante). 
Acknowledgments: Enrique Albert Pérez for contributions discussing the main results. 
Conflicts of Interest: The authors report no conflict of interest. 
References 
1. Franceschi, C.; Garagnani, P.; Gensous, N.; Bacalini, M.G.; Conte, M.; Salvioli, S. Accelerated bio-cognitive 
aging in Down syndrome: State of the art and possible deceleration strategies. Aging Cell 2019, 18, e12903, 
doi:10.1111/acel.12903. 
2. Whooten, R.; Schmitt, J.; Schwartz, A. Endocrine manifestations of Down syndrome. Curr. Opin. Endocrinol. 
Diabetes Obes. 2018, 25, 61–66, doi:10.1097/med.0000000000000382. 
3. Kennedy, B.K.; Berger, S.L.; Brunet, A.; Campisi, J.; Cuervo, A.M.; Epel, E.S.; Franceschi, C.; Lithgow, G.J.; 
Morimoto, R.I.; Pessin, J.E.; et al. Geroscience: Linking aging to chronic disease. Cell 2014, 159, 709–713, 
doi:10.1016/j.cell.2014.10.039. 
4. Tzanetakou, I.P.; Katsilambros, N.L.; Benetos, A.; Mikhailidis, D.P.; Perrea, D.N. Is obesity linked to aging? 
Ageing Res. Rev. 2012, 11, 220–229, doi:10.1016/j.arr.2011.12.003. 
5. Hsieh, K.; Rimmer, J.H.; Heller, T. Obesity and associated factors in adults with intellectual disability. J. 
Intellect. Disabil. Res. 2013, 58, 851–863, doi:10.1111/jir.12100. 
6. Bertapelli, F.; Pitetti, K.H.; Agiovlasitis, S.; Guerra-Junior, G. Overweight and obesity in children and ado-
lescents with Down syndrome—prevalence, determinants, consequences, and interventions: A literature 
review. Res. Dev. Disabil. 2016, 57, 181–192, doi:10.1016/j.ridd.2016.06.018. 
7. Brantmüller, É.; Gyuró, M.; Karácsony, I. Development of Walking and Self-sufficiency Ability Related to 
Nutrition among People with Down Syndrome. Pr. Theory Syst. Educ. 2015, 10, 165–176, doi:10.1515/ptse-
2015-0016. 
8. Cushing, P.; Spear, D.; Novak, P.; Rosenzweig, L.; Wallace, L.S.; Conway, C.; Wittenbrook, W.; Lemons, S.; 
Medlen, J.G. Academy of Nutrition and Dietetics: Standards of Practice and Standards of Professional Per-
formance for Registered Dietitians (Competent, Proficient, and Expert) in Intellectual and Developmental 
Disabilities. J. Acad. Nutr. Diet. 2012, 112, 1454–1464.e35, doi:10.1016/j.jand.2012.06.365. 
9. Frasca, D.; Blomberg, B.B. Adipose Tissue Inflammation Induces B Cell Inflammation and Decreases B Cell 
Function in Aging. Front. Immunol. 2017, 8, 1003, doi:10.3389/fimmu.2017.01003. 
10. Capone, G.; Chicoine, B.; Bulova, P.; Stephens, M.; Hart, S.J.; Crissman, B.; Videlefsky, A.; Myers, K.; Roizen, 
N.; Esbensen, A.; et al. Co-occurring medical conditions in adults with Down syndrome: A systematic re-
view toward the development of health care guidelines. Am. J. Med. Genet. Part A 2017, 176, 116–133, 
doi:10.1002/ajmg.a.38512. 
11. Harris, L.; Melville, C.; Murray, H.; Hankey, C. The effects of multi-component weight management inter-
ventions on weight loss in adults with intellectual disabilities and obesity: A systematic review and meta-
analysis of randomised controlled trials. Res. Dev. Disabil. 2018, 72, 42–55, doi:10.1016/j.ridd.2017.10.021. 
12. Ulijaszek, S.J.; A Kerr, D. Anthropometric measurement error and the assessment of nutritional status. Br. 
J. Nutr. 1999, 82, 165–177, doi:10.1017/s0007114599001348. 
13. Madden, A.M.; Smith, S. Body composition and morphological assessment of nutritional status in adults: 
A review of anthropometric variables. J. Hum. Nutr. Diet. 2014, 29, 7–25, doi:10.1111/jhn.12278. 
14. Hume, P.; Marfell-Jones, M. The importance of accurate site location for skinfold measurement. J. Sports 
Sci. 2008, 26, 1333–1340, doi:10.1080/02640410802165707. 
Int. J. Environ. Res. Public Health 2020, 17, 4294 16 of 18 
 
15. Nádas, J.; Putz, Z.; Kolev, G.; Nagy, S.; Jermendy, G. Intraobserver and interobserver variability of meas-
uring waist circumference. Med. Sci. Monit. 2008, 14, 15–18. 
16. Gil, A.; Martínez de Victoria, E.; Maldonado, J. Tratado de Nutrición, 2nd ed.; Médica Panamericana: Madrid, 
Spain, 2010; Volumen 3, pp. 100–131. 
17. Müller, M.; Braun, W.; Pourhassan, M.; Geisler, C.; Bosy-Westphal, A. Application of standards and models 
in body composition analysis. Proc. Nutr. Soc. 2015, 75, 181–187, doi:10.1017/s0029665115004206. 
18. Liberati, A.; Altman, D.G.; Tetzlaff, J.; Mulrow, C.; Gøtzsche, P.C.; Ioannidis, J.P.A.; Clarke, M.; Devereaux, 
P.J.; Kleijnen, J.; Moher, D. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses 
of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med. 2009, 6, 
e1000100, doi:10.1371/journal.pmed.1000100. 
19. The International Committee of Biomedical Journal Editors (ICMJE). Recommendations for the Prepara-
tion, Presentation, Editing and Publication of Academic Papers in Medical Journal. 2017. Available online: 
http://www.icmje.org/icmje-recommendations.pdf (accessed on 8 November 2019). 
20. Wiesman, F.; Hasman, A.; Herik, H.V.D. Information retrieval: An overview of system characteristics. Int. 
J. Med. Inform. 1997, 47, 5–26, doi:10.1016/s1386-5056(97)00094-4. 
21. Ptomey, L.T.; Wittenbrook, W. Position of the Academy of Nutrition and Dietetics: Nutrition Services for 
Individuals with Intellectual and Developmental Disabilities and Special Health Care Needs. J. Acad. Nutr. 
Diet. 2015, 115, 593–608, doi:10.1016/j.jand.2015.02.002. 
22. Rodd, C.J.; the Canadian Pediatric Endocrine Group (CPEG) Working Committee for National Growth 
Charts; Metzger, D.; Sharma, A.K. Extending World Health Organization weight-for-age reference curves 
to older children. BMC Pediatr. 2014, 14, 32, doi:10.1186/1471-2431-14-32. 
23. The 10 Most Spoken Languages in the World. Descarga en. Available online: https://danivoiceo-
vers.com/en/los-10-idiomas-mas-hablados-mundo/ (accessed on 16 May 2020). 
24. Los Idiomas, en Cifras: Cuántas Lenguas Hay en el Mundo? Europapress. Descarga en. Available online: 
https://www.europapress.es/sociedad/noticia-idiomas-cifras-cuantas-lenguas-hay-mundo-
20190221115202.html (accessed on 16 May 2020). 
25. Seron, B.B.; Silva, R.A.; Greguol, M. Effects of two programs of exercise on body composition of adoles-
cents with Down syndrome. Rev. Paul. Pediatr. 2014, 32, 92–98. 
26. Constanza Mosso, C.; Patricia Santander, V.; Paulina Pettinelli, R.; Marcela Valdés, G.; Magdalena Celis, B.; 
Fabián Espejo, S. Evaluation of a physical activity intervention among children with down’s syndrome. Rev. 
Chil. Pediatr. 2011, 82, 311–318. 
27. Ordonez, F.J.; Rosety, M.; Rosety-Rodriguez, M. Influence of 12-week exercise training on fat mass per-
centage in adolescents with Down syndrome. Med. Sci. Monit. 2006, 12, CR416–CR419. 
28. Boer, P.-H.; Moss, S.J. Effect of continuous aerobic vs. interval training on selected anthropometrical, phys-
iological and functional parameters of adults with Down syndrome. J. Intellect. Disabil. Res. 2016, 60, 322–
334, doi:10.1111/jir.12251. 
29. Ordonez, F.J.; Fornieles, G.; Rosety, M.A.; Rosety, I.; Diaz, A.J.; Camacho, A. A Short Training Pro-gram 
Reduced Fat Mass and Abdominal Distribution in Obese Women with Intellectual Disability. Int. J. Morphol. 
2013, 31, 570–574. Available online: https://scielo.conicyt.cl/scielo.php?script=sci_abstract&pid=S0717-
95022013000200034&lng=es&nrm=iso&tlng=en (accessed on 8 November 2019). 
30. Ordonez, F.J.; Fornieles-Gonzalez, G.; Camacho, A.; Rosety, M.A.; Rosety, I.; Diaz, A.J.; Rodríguez, J.R. 
Anti-inflammatory effect of exercise, via reduced leptin levels, in obese women with Down syndrome. Int. 
J. Sport Nutr. Exerc. Metab. 2012, 23, 239–244, doi:10.1123/ijsnem.23.3.239. 
31. Ogg-Groenendaal, M.; Hermans, H.; Claessens, B. A systematic review on the effect of exercise interven-
tions on challenging behavior for people with intellectual disabilities. Res. Dev. Disabil. 2014, 35, 1507–1517, 
doi:10.1016/j.ridd.2014.04.003. 
32. Shin, I.-S.; Park, E.-Y. Meta-analysis of the effect of exercise programs for individuals with intellectual dis-
abilities. Res. Dev. Disabil. 2012, 33, 1937–1947, doi:10.1016/j.ridd.2012.05.019. 
33. Es, L.R.R.; Resende, E.S.; Diniz, A.L.D.; Penha-Silva, N.; O’Connell, J.L.; Gomes, P.F.S.; Zanetti, H.R.; 
Roerver-Borges, A.S.; Veloso, F.C.; De Souza, F.R.; et al. Epicardial adipose tissue and metabolic syndrome. 
Medicine 2018, 97, e0387, doi:10.1097/md.0000000000010387. 
34. Moher, D.; Hopewell, S.; Schulz, K.F.; Montori, V.M.; Gøtzsche, P.C.; Devereaux, P.J.; Elbourne, D.; Egger, 
M.; Altman, U.G. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel 
group randomised trials. Int. J. Surg. 2012, 10, 28–55, doi:10.1016/j.ijsu.2011.10.001. 
Int. J. Environ. Res. Public Health 2020, 17, 4294 17 of 18 
 
35. Fields, D.A.; Higgins, P.B.; Radley, D. Air-displacement plethysmography: Here to stay. Curr. Opin. Clin. 
Nutr. Metab. Care 2005, 8, 624–629, doi:10.1097/01.mco.0000171127.44525.07. 
36. Kyle, U.G.; Bosaeus, I.; De Lorenzo, A.D.; Deurenberg, P.; Elia, M.; Gómez, J.M.; Heitmann, B.L.; Kent-
Smith, L.; Melchior, J.-C.; Pirlich, M.; et al. Bioelectrical impedance analysis-part II: Utilization in clinical 
practice. Clin. Nutr. 2004, 23, 1430–1453, doi:10.1016/j.clnu.2004.09.012. 
37. WHO. Human Genomics in Global Health. Available online: https://www.who.int/genomics/public/ge-
neticdiseases/en/index1.html (accessed on 27 May 2020). 
38. Müller, M.; Bosy-Westphal, A. Effect of Over- and Underfeeding on Body Composition and Related Meta-
bolic Functions in Humans. Curr. Diabetes Rep. 2019, 19, 108, doi:10.1007/s11892-019-1221-7. 
39. Bray, G.; E Heisel, W.; Afshin, A.; Jensen, M.D.; Dietz, W.H.; Long, M.W.; Kushner, R.F.; Daniels, S.R.; A 
Wadden, T.; Tsai, A.G.; et al. The Science of Obesity Management: An Endocrine Society Scientific State-
ment. Endocr. Rev. 2018, 39, 79–132, doi:10.1210/er.2017-00253. 
40. Garvey, W.T.; Mechanick, J.I.; Brett, E.M.; Garber, A.J.; Hurley, D.L.; Jastreboff, A.M.; Nadolsky, K.; Pessah-
Pollack, R.; Plodkowski, R. American Association of Clinical Endocrinologist and American College of En-
docrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with obesity. Endocr. 
Pr. 2016, 22, 1–203, doi:10.4158/ep161365.gl. 
41. Yumuk, V.; Tsigos, C.; Fried, M.; Schindler, K.; Busetto, L.; Micic, A.; Toplak, H.; Obesity Management Task 
Force of the European Association for the Study of Obesity European Guidelines for Obesity Management 
in Adults. Obes. Facts 2015, 8, 402–424, doi:10.1159/000442721. 
42. Fitch, A.; Fox, C.; Bauerly, K.; Gross, A.; Heim, C.; Judge-Dietz, J.; Kaufman, T.; Krych, E.; Kumar, S.; Landin, 
D.; et al. Prevention and Management of Obesity for Children and Adolescents. Institute for Clinical Sys-
tems Improvement. Available online: https://www.healthpartners.com/ucm/groups/public/@hp/@pub-
lic/documents/documents/cntrb_037112.pdf (accessed on 11 November 2019). 
43. Garber, C.E.; Blissmer, B.; Deschenes, M.R.; Franklin, B.A.; Lamonte, M.J.; Lee, I.M. American Col-lege of 
Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardi-
orespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescrib-
ing exercise. Med. Sci. Sports Exerc. 2011, 43, 1334–1359, doi:10.1249/MSS.0b013e318213fefb. 
44. Donnelly, J.E.; Blair, S.N.; Jakicic, J.M.; Manore, M.M.; Rankin, J.W.; Smith, B.K. Appropriate Physical Ac-
tivity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults. Med. Sci. Sports 
Exerc. 2009, 41, 459–471, doi:10.1249/mss.0b013e3181949333. 
45. Grondhuis, S.N.; Aman, M.G. Overweight and obesity in youth with developmental disabilities: A call to 
action. J. Intellect. Disabil. Res. 2013, 58, 787–799, doi:10.1111/jir.12090. 
46. Argimon, J.M.; Jimenéz, J. Métodos de Investigación Clínica y Epidemiológica, 4th ed.; Elsevier: Barcelona, Spain, 
2013. 
47. Pitchford, E.A.; Adkins, C.; Hasson, R.E.; Hornyak, J.E.; Ulrich, D. Association between Physical Activity 
and Adiposity in Adolescents with Down Syndrome. Med. Sci. Sports Exerc. 2018, 50, 667–674, 
doi:10.1249/mss.0000000000001502. 
48. Loyen, A.; Clarke-Cornwell, A.; Anderssen, S.A.; Hagströmer, M.; Sardinha, L.B.; Sundquist, K.; Ekelund, 
U.; Steene-Johannessen, J.; Baptista, F.; Hansen, B.H.; et al. Sedentary Time and Physical Activity Surveil-
lance Through Accelerometer Pooling in Four European Countries. Sports Med. 2016, 47, 1421–1435, 
doi:10.1007/s40279-016-0658-y. 
49. Pastore, E.; Marino, B.; Calzolari, A.; Digilio, M.C.; Giannotti, A.; Turchetta, A. Clinical and cardiorespira-
tory assessment in children with Down syndrome without congenital heart disease. Arch. Pediatr. Adolesc. 
Med. 2000, 154, 408–410, doi:10.1001/archpedi.154.4.408. 
50. Carvalho, T.; Massetti, T.; Da Silva, T.D.; Crocetta, T.B.; Guarnieri, R.; De Abreu, L.C.; Monteiro, C.B.D.M.; 
Garner, D.M.; Ferreira, C. Heart rate variability in individuals with Down syndrome—A systematic review 
and meta-analysis. Auton. Neurosci. 2018, 213, 23–33, doi:10.1016/j.autneu.2018.05.006. 
  
Int. J. Environ. Res. Public Health 2020, 17, 4294 18 of 18 
 
51. Oppewal, A.; Hilgenkamp, T.I.M.; Van Wijck, R.; Evenhuis, H.M. Cardiorespiratory fitness in individuals 
with intellectual disabilities—A review. Res. Dev. Disabil. 2013, 34, 3301–3316, doi:10.1016/j.ridd.2013.07.005. 
52. Nixon, D. Down Syndrome, Obesity, Alzheimer’s Disease, and Cancer: A Brief Review and Hypothesis. 
Brain Sci. 2018, 8, 53, doi:10.3390/brainsci8040053. 
 
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
 
